SynBioBeta Speaker
Amy Jenkins
Senior Director, Strategy and Operations
AstraZeneca
May 2026, SynBioBeta
Speaker
Dr. Amy Jenkins is currently the Senior Director of Strategy and Operations within the Vaccines and Immune Therapies Unit at AstraZeneca. Prior to joining AstraZeneca, Dr. Jenkins was the Acting Deputy Director of the Advanced Research Projects Agency for Health (ARPA-H) assisting in the management of the agency from a strategic planning and scientific perspective. She served as the inaugural director of the Health Science Futures Office within ARPA-H where she managed a diverse office focused on revolutionary technology innovations in osteoarthritis, cancer, cell and gene therapy, vaccinology, manufacturing, and neuroscience. She also served as a program manager in the Biological Technologies Office at DARPA. Her portfolio included programs aimed at the development of platforms for combatting infectious disease threats using nucleic acid vectored monoclonal antibodies and novel synthetic biology tools. She had a particular focus within her portfolio on novel manufacturing methods to enable rapid response. She has served as a Project Coordination Team lead for Operation Warp Speed, driving the development of monoclonal antibodies for the treatment and prevention of covid-19 disease.She received her Doctor of Philosophy degree in Chemistry and Chemical Biology from Cornell University and her Bachelor of Science in Chemistry and Biomolecular Science from Clarkson University.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Before Midnight Thu, Dec 4
24:13:47:01
Regular Rate
$2,995
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.